Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Total Debt (2016 - 2025)

Palisade Bio (PALI) has disclosed Total Debt for 10 consecutive years, with $235000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Total Debt changed N/A to $235000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $235000.0, a N/A change, with the full-year FY2023 number at $143000.0, changed N/A from a year prior.
  • Total Debt was $235000.0 for Q3 2025 at Palisade Bio, up from $66000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $1.1 million in Q2 2021 to a low of $66000.0 in Q2 2025.
  • A 3-year average of $396250.0 and a median of $189000.0 in 2023 define the central range for Total Debt.